SYBX

Welcome to the Brand page for “SYBX”, which is offered here for Pharmaceutical preparations and therapeutic agents in the nature of engineered or biologically-modified microbes for the treatment of gastrointestinal diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, cancer, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, dermatological diseases and disorders, genitourinary diseases and disorders and other diseases and disorders;assistance in business management and product commercialization; and/or advertising services, for third parties, in connection with the commercialization and sale of therapeutic products and diagnostic products, both using engineered or biologically modified microbes; providing business consulting services in the field of therapeutic and diagnostic products, assistance in product commercialization of therapeutic and diagnostic products using engineered or biologically modified microbes;diagnostic products, diagnostic preparations for clinical or medical laboratory use;research, development and commercialization of therapeutic products using engineered or biologically modified microbes; research, development and commercialization of diagnostic products using engineered or biologically modified microbes;.

Its status is currently believed to be active. Its class is unavailable. “SYBX” is believed to be currently owned by “Synlogic, Inc.”